Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Q2 2024 Earnings Call Transcript August 13, 2024
Operator: Welcome to Calliditas Q2 2024 Report. [Operator Instructions] And there will be no Q&A session after the presentation. Now I will hand the conference over to the speakers. Please go ahead.
Renée Aguiar-Lucander: Thank you very much. Welcome to our Q2 2024 report. My name is Renée Aguiar-Lucander, CEO of Calliditas. And I’m joined today by Richard Philipson, Chief Medical Officer;...
